Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	<18 mg SPN-810	38
Overall Study	STARTED	18 mg to < 24 mg SPN-810	159
Overall Study	STARTED	24 mg to < 36 mg SPN-810	131
Overall Study	STARTED	36 mg to ≤54 mg SPN-810	163
Overall Study	COMPLETED	<18 mg SPN-810	0
Overall Study	COMPLETED	18 mg to < 24 mg SPN-810	1
Overall Study	COMPLETED	24 mg to < 36 mg SPN-810	2
Overall Study	COMPLETED	36 mg to ≤54 mg SPN-810	1
Overall Study	NOT COMPLETED	<18 mg SPN-810	38
Overall Study	NOT COMPLETED	18 mg to < 24 mg SPN-810	158
Overall Study	NOT COMPLETED	24 mg to < 36 mg SPN-810	129
Overall Study	NOT COMPLETED	36 mg to ≤54 mg SPN-810	162

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02691182/flow